Results 81 to 90 of about 100,610 (328)

The role of the host—Neutrophil biology

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Neutrophilic polymorphonuclear leukocytes (neutrophils) are myeloid cells packed with lysosomal granules (hence also called granulocytes) that contain a formidable antimicrobial arsenal. They are terminally differentiated cells that play a critical role in acute and chronic inflammation, as well as in the resolution of inflammation and wound ...
Iain L. C. Chapple   +4 more
wiley   +1 more source

Botulinum neurotoxin formulations: overcoming the confusion

open access: yesClinical, Cosmetic and Investigational Dermatology, 2018
Souphiyeh Samizadeh,1 Koenraad De Boulle2 1Great British Academy of Aesthetic Medicine, London, UK; 2Aalst Dermatology Clinic, Aalst, Belgium Abstract: Botulinum toxin A is produced by anaerobic spore-forming bacteria and is used for various therapeutic ...
Samizadeh S, De Boulle K
doaj  

Botulinum Toxin-A in Dystonia

open access: yesPediatric Neurology Briefs, 1990
A report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology concludes that local injection of type A botulinum toxin (Botox) is proven as a safe and efficacious modality for the treatment of blepharospasm, cervical dystonia, and hemifacial spasm.
openaire   +3 more sources

Long‐Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN‐Open‐Label Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister   +11 more
wiley   +1 more source

An integrated, cost-effective efficient chain to deliver botulinum toxin in optimal conditions.

open access: yesInternational Journal of Integrated Care, 2019
Introduction: Botulinum toxin is increasingly used in clinical care for a variety of conditions that include facial spasms, bleharospasms, and other abnormal movement disorders.
Marian Gomez Beldarrain   +4 more
doaj   +1 more source

Botulinum toxin application to the buccinator muscle in the treatment of facial synkinesis: a prospective cohort study

open access: yesAustralasian Journal of Plastic Surgery
**Background**: Synkinesis may develop following facial nerve palsy, impacting quality of life. Botulinum toxin treatment for synkinesis is commonly used, but buccinator muscle injection is less common.
Raymond Hayler   +4 more
doaj   +1 more source

Long-term efficacy of spasticity-corrective surgery and botulinum toxin injections for upper limb spasticity treatment

open access: yesJournal of Rehabilitation Medicine - Clinical Communications
Objective: To evaluate the long-term efficacy of spasticity-corrective surgery and botulinum toxin treatment in patients with upper limb spasticity. Design: Pretest-posttest quasi-experimental study.
Therese Ramström   +4 more
doaj   +1 more source

Computer Vision Technologies in Movement Disorders: A Systematic Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Evaluation of movement disorders primarily relies on phenomenology. Despite refinements in diagnostic criteria, the accuracy remains suboptimal. Such a gap may be bridged by machine learning and video technology, which permit objective, quantitative, non‐invasive motor analysis.
Pasquale Maria Pecoraro   +4 more
wiley   +1 more source

Double Sandwich ELISA Modified Method for the Detection of Clostridium Botulinum Type E [PDF]

open access: yesJournal of Fasa University of Medical Sciences, 2013
Background & Objective: A very small amount of botulinum toxin can cause death and on the other hand, there is no cure for its poison other than antitoxin.
Mohammad Ebrahim minaei, Mojtaba Saadati
doaj   +1 more source

Optimizing Botulinum Toxin Injections in the Platysma Muscle Based on Motor Nerve Distribution. [PDF]

open access: yesJ Cosmet Dermatol
ABSTRACT Background Platysmal bands contribute to neck ageing and lower‐face descent. Although botulinum toxin A (BoNT‐A) is approved for this indication, conventional whole‐muscle dosing requires many superficial injections with attendant risks.
Yi KH, Wong IKJ, Wan J.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy